Intra-Cellular Therapies Inc
F:23I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intra-Cellular Therapies Inc
F:23I
|
US |
|
Dart Mining NL
ASX:DTM
|
AU |
|
Exail Technologies SA
PAR:EXA
|
FR |
|
NewPrinces SpA
F:6NF
|
IT |
|
B
|
BJC Heavy Industries PCL
SET:BJCHI
|
TH |
|
Netcompany Group A/S
OTC:NTCYF
|
DK |
|
Globe Metals and Mining Ltd
ASX:GBE
|
AU |
|
Piaggio & C SpA
OTC:PIAGF
|
IT |
|
Contango Silver & Gold Inc
F:F85
|
US |
|
B
|
Blessed Assets Group Co Ltd PCL
SET:BLESS
|
TH |
|
Strongpoint ASA
OSE:STRO
|
NO |
|
C
|
Chase Asia PCL
SET:CHASE
|
TH |
|
S
|
SPVI PCL
SET:SPVI
|
TH |
Shareholder Yield
Current shareholder yield for 23I is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
23I Price
Intra-Cellular Therapies Inc
| Average Annual Return | 29.24% |
| Standard Deviation of Annual Returns | 18.31% |
| Max Drawdown | -23% |
| Market Capitalization | 13B EUR |
| Shares Outstanding | 105 575 000 |
| Percentage of Shares Shorted |
N/A
|
